Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06112093 · ClinicalTrials.gov registry record · Phase 1
Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches
A Phase 1 study of Mild Traumatic Brain Injury and Headache, sponsored by State University of New York - Upstate Medical University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06112093 is a Phase 1 study of Mild Traumatic Brain Injury and Headache that is actively recruiting participants, run by State University of New York - Upstate Medical University. The registered enrollment target is 60 participants, below the 219-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06112093, a Phase 1 study of Mild Traumatic Brain Injury and Headache, is actively recruiting participants, sponsored by State University of New York - Upstate Medical University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to examine the long-term effect of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, on chronic headaches following mild traumatic brain injury (mTBI). rTMS has been shown to be effective in reducing chronic headaches without side effects commonly seen in medications, such as sleepiness and addiction. This study uses rTMS to manage chronic headaches to improve post-concussion symptoms and reduce the economic burden due to delayed recovery. This project aims to better identify biomarkers for diagnosis and prognosis and maximize recovery from mTBI.
Conditions Studied
Interventions
- DEVICE Repetitive Transcranial Magnetic Stimulation
- DEVICE Sham Repetitive Transcranial Magnetic Stimulation
Study Locations (1)
New York
- SUNY Upstate Medical University - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-10-23 |
| Est. Completion | 2027-10-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06112093
The ClinicalTrials.gov registry entry for NCT06112093 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (73% lower). The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Repetitive Transcranial Magnetic Stimulation is the first listed.
NCT06112093 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06112093 about?
NCT06112093 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches". This study aims to examine the long-term effect of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, on chronic headaches following mild traumatic brain injury (mTBI). rTMS has been shown to be effective in reducing chronic headaches without side effect...
What is the current status of trial NCT06112093?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2023-10-23. Estimated completion is 2027-10-23.
What conditions does trial NCT06112093 study?
This clinical trial studies the following conditions: Mild Traumatic Brain Injury, Headache, Brain Concussion, Post-Concussion Symptoms.
What interventions are being tested in trial NCT06112093?
The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (DEVICE), Sham Repetitive Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT06112093?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06112093 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Regulation of Emotion, Sleep Extension, and mTBI
RECRUITING · Phase 1
-
Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury
RECRUITING · Phase 1
-
Biological Signatures, Probiotic Among Those With mTBI and PTSD
COMPLETED · Phase 1
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Vestibular Rehabilitation App for Adults With Dizziness Related to mTBI
RECRUITING · NA
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.